CADASIL presenting as status migrainosus and persisting aura without infarction.
Different types of migraine have been reported in 20-40% of patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). We describe a novel migrainous manifestation of CADASIL consisting in status migrainosus and persistent aura without infarction. The symptoms resolved after i.v. treatment with lorazepam and mannitol.
Sacco
Simona
S
Department of Neurology, The Regional Headache Referral Center, University of L'Aquila, L'Aquila, Italy.
Rasura
Maurizia
M
Cao
Marina
M
Bozzao
Alessandro
A
Carolei
Antonio
A
D000328:Adult; D000927:Anticonvulsants / Q000008:administration & dosage; D046589:CADASIL / Q000150:complications* / Q000175:diagnosis / Q000503:physiopathology*; D004234:Diuretics, Osmotic / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008140:Lorazepam / Q000008:administration & dosage; D008353:Mannitol / Q000008:administration & dosage; D008881:Migraine Disorders / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology*; D020325:Migraine with Aura / Q000188:drug therapy / Q000503:physiopathology*; D016896:Treatment Outcome
D000927:Anticonvulsants; D004234:Diuretics, Osmotic; D008353:Mannitol; D008140:Lorazepam